Healthcare provider profile · identity verified

John D Danzell, MD

Family Practice · SHREVEPORT, LA · NPI 1821173535

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	337	100
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	237	82
Methylprednisolone	Methylprednisolone	176	89
Atorvastatin Calcium	Atorvastatin Calcium	174	42
Cefuroxime	Cefuroxime Axetil	139	96
Alprazolam	Alprazolam	130	37
Potassium Chloride	Potassium Chloride	119	35
Metformin Hcl	Metformin Hcl	114	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	113	67
Pantoprazole Sodium	Pantoprazole Sodium	102	27
Albuterol Sulfate Hfa	Albuterol Sulfate	89	21
Metoprolol Succinate	Metoprolol Succinate	89	20
Omeprazole	Omeprazole	80	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	78	43
Hydralazine Hcl	Hydralazine Hcl	77	27
Zolpidem Tartrate	Zolpidem Tartrate	76	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	75	24
Tizanidine Hcl	Tizanidine Hcl	75	17
Nifedipine Er	Nifedipine	71	18
Levothyroxine Sodium	Levothyroxine Sodium	67	21
Losartan Potassium	Losartan Potassium	66	20
Doxycycline Hyclate	Doxycycline Hyclate	56	34
Famotidine	Famotidine	53	17
Tamsulosin Hcl	Tamsulosin Hcl	53	suppressed
Gabapentin	Gabapentin	51	12
Glipizide	Glipizide	50	17
Carvedilol	Carvedilol	47	11
Metoprolol Tartrate	Metoprolol Tartrate	47	suppressed
Lisinopril	Lisinopril	45	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	41	18
Clopidogrel	Clopidogrel Bisulfate	40	suppressed
Fluconazole	Fluconazole	40	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Methocarbamol	Methocarbamol	33	suppressed
Trazodone Hcl	Trazodone Hcl	33	suppressed
Clonidine Hcl	Clonidine Hcl	32	11
Montelukast Sodium	Montelukast Sodium	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Carisoprodol	Carisoprodol	26	14
Amoxicillin	Amoxicillin	25	16
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Furosemide	Furosemide	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Promethazine Hcl	Promethazine Hcl	25	suppressed
Meclizine Hcl	Meclizine Hcl	24	12
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Eliquis	Apixaban	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	22	suppressed
Ibuprofen	Ibuprofen	22	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	22	suppressed
Allopurinol	Allopurinol	21	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Felodipine Er	Felodipine	18	suppressed
Linzess	Linaclotide	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Prednisone	Prednisone	17	13
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	12
Finasteride	Finasteride	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Simvastatin	Simvastatin	14	suppressed
Clonidine	Clonidine	13	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Ramipril	Ramipril	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Levofloxacin	Levofloxacin	11	11
Sertraline Hcl	Sertraline Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error